The vascular grafts market would grow at a CAGR of 5.24% over the predicted time frame. The market is expected to increase in value from US$ 5.65 Bn in 2022 to US$ 8.5 Bn in 2030.
The on vascular
grafts Market, which provides a business strategy, research & development
activities, concise outline of the market valuation, valuable insights
pertaining to market share, size, supply chain analysis, competitive landscape
and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1758
Report Scope of the Vascular Grafts Market
| Report Coverage | Details |
| Market Size by 2030 | USD 8.5 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.24% |
| North America Market Share in 2021 | 31% |
| Endovascular Stent Grafts Market Share in 2021 | 64% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Raw Material, Geography |
| Companies Mentioned | Getinge AB, Medtronic PLC, LeMaitre vascular Inc, WL gore and associates, terumo corporation, Shanghai suokang medical implants Co limited, Cook medical |
A recent
report provides crucial insights along with application based and forecast
information in the Global Vascular grafts Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Vascular grafts market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Vascular grafts market
are included as given below:
Vascular grafts Market Key Players
- Getinge AB
- Medtronic PLC
- LeMaitre vascular Inc
- WL gore and associates
- terumo corporation
- Shanghai suokang medical implants Co limited
- Cook medical
Recent Developments
Market Segments
- Vascular Grafts for Aorta Disease
- Peripheral Vascular Grafts
- Endovascular Stent Grafts
- Coronary Artery By-Pass Grafts
By Application
- Cardiac Aneurysm
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Disease
By Raw Material
- Polyester Vascular Grafts
- Polytetrafluoroethylene Vascular Grafts
- Polyurethane Vascular Grafts
- Biological Material Based Vascular Grafts
- Human Saphenous and Umbilical Veins
- Tissue Engineered Materials
By End User
- Hospitals
- Ambulatory Surgical Centers
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global vascular
grafts market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the vascular
grafts market
Table of ContentChapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Vascular Grafts Market
5.1. COVID-19 Landscape: Vascular Grafts Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Vascular Grafts Market, By Product
8.1. Vascular Grafts Market, by Product Type, 2022-2030
8.1.1. Vascular Grafts for Aorta Disease
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Peripheral Vascular Grafts
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Endovascular Stent Grafts
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Coronary Artery By-Pass Grafts
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Vascular Grafts Market, By End Use
9.1. Vascular Grafts Market, by End Use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Vascular Grafts Market, By Application Type
10.1. Vascular Grafts Market, by Application Type, 2022-2030
10.1.1. Cardiac Aneurysm
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Kidney Failure
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Vascular Occlusion
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Coronary Artery Disease
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Vascular Grafts Market, By Raw Material Type
11.1. Vascular Grafts Market, by Raw Material Type, 2022-2030
11.1.1. Polyester Vascular Grafts
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Polytetrafluoroethylene Vascular Grafts
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Polyurethane Vascular Grafts
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Biological Material Based Vascular Grafts
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Human Saphenous and Umbilical Veins
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Tissue Engineered Materials
11.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
Chapter 13. Company Profiles
13.1. Getinge AB
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic PLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. LeMaitre vascular Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. WL gore and associates
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. terumo corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Shanghai suokang medical implants Co limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cook Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments